Interestingly, when additional baseline immune parameters were investigated, placebo subjects not progressing to shigellosis were found to have significantly higher LPS-specific memory B cell IgA responses on the day of challenge as compared to placebo subjects with shigellosis (p = 0·035 [T-Test of log-transformed titres]; data not shown). Here, CD79A is linked to shigellosis.